Stay updated on YH001 Plus Envafolimab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the YH001 Plus Envafolimab in Sarcoma Clinical Trial page.

Latest updates to the YH001 Plus Envafolimab in Sarcoma Clinical Trial page
- CheckyesterdayChange DetectedRevision 3.5.0 was added to the Record History, and revision 3.4.3 was removed.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a new revision entry 'v3.4.3' to the record history and removed the previous 'v3.4.2' entry.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new Revision: v3.4.2 was added to the history, and prior notices about funding lapse and Revision: v3.4.1 were removed, reflecting an administrative site update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check44 days agoChange DetectedA new site-wide funding notice was added and the page version updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check51 days agoChange DetectedGlossary toggle added; additions are shown in green and deletions in red to highlight changes in the Record History, with the latest revision labeled v3.4.0. A No FEAR Act Data note is now present and the earlier v3.3.4 reference has been removed.SummaryDifference1%

- Check65 days agoChange DetectedRevision: v3.3.4 was added. Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to YH001 Plus Envafolimab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the YH001 Plus Envafolimab in Sarcoma Clinical Trial page.